Ciena's multi-rail Hyper-Rail platform win marks a multi-year, high-margin growth catalyst, with deployment ramping in FY27.

On June 26, Melissa Brown, Managing Director of Investment Decision Research at SimCorp, joined BNN Bloomberg to discuss current market volatility despite a previously strong performance, ...

Objective Sarcopenia, defined by reductions in muscle mass and strength, increases the risk of adverse outcomes in patients with rheumatoid arthritis (RA)—driven in part by chronic inflammation—and is ...

Researchers combined observations and modeling to track the movement of the Congo’s freshwater plume, noting that eddies play ...

GE HealthCare announced the introduction of Allia platform upgrade pathways that are designed to help customers modernize select l ...

In this panel discussion, four leading FFF experts share their perspectives on where the technique stands today and where it ...

Dissecting protective versus detrimental immune responses uncovers biomarkers and mechanisms that can inform the rational design and evaluation of live attenuated vaccines against African swine fever ...

Interferon receptor knockout chickens uncover how type I and III interferons differentially shape avian antiviral immunity and influenza disease outcomes.

From the rugged capabilities of STOL aircraft to the refinement of the modern personal aircraft supported by MOSAIC, the ...

Sivers Semiconductors has added partnerships, production orders, and several potential growth drivers. Read what investors ...

With roles as a clinician, professor, researcher, director and company founder, Ruchi Gupta, MD, MPH, has a lot to juggle — ...